Publications by authors named "Shreya Bandopadhyay"

Article Synopsis
  • - The study investigates the impact of a CLIP antagonist peptide (CAP) on B cell expansion and neuroprotective effects in 5xFAD mice, which are a model for Alzheimer's disease and have a history of traumatic brain injury (TBI).
  • - Results showed that treatment with CAP significantly reduced CLIP-positive B cells and improved various impairments related to the immune system and neurobehavioral functions in the 5xFAD mice over a period of six months.
  • - However, TBI seemed to negate the effectiveness of CAP in reducing B cell populations and also exacerbated several pathological features of Alzheimer's disease, indicating a complex interaction between TBI and AD.
View Article and Find Full Text PDF

Homeobox gene families are associated with embryonic development and organogenesis. Pieces of evidence suggest that these Homeobox genes are also crucial in facilitating oncogenesis when mutated or overexpressed. Paired homeodomain transcription factor-2 (PITX2), one of the members of this family, is involved in oncogenic regulation apart from its different development regulatory functions.

View Article and Find Full Text PDF

Ovarian cancer ranks fifth in terms of cancer mortality in women due to lack of early diagnosis and poor clinical management. Characteristics like high cellular proliferation, EMT and metabolic alterations contribute to oncogenicity. Cancer, being a "metabolic disorder," is governed by various key regulatory factors like metabolic enzymes, oncogenes, and tumor suppressors.

View Article and Find Full Text PDF

The original version of this article unfortunately contained an error in acknowledgment text. The authors would like to include a statement: "Moumita Dasgupta is supported by Junior Research Fellowship from University Grant Commission, India." in acknowledgment section.

View Article and Find Full Text PDF

Paclitaxel is one of the most commonly used drugs for the treatment of nonsmall cell lung cancer (NSCLC). However acquired resistance to paclitaxel, epithelial to mesenchymal transition and cancer stem cell formation are the major obstacles for successful chemotherapy with this drug. Some of the major reasons behind chemoresistance development include increased ability of the cancer cells to survive under stress conditions by autophagy, increased expression of drug efflux pumps, tubulin mutations etc.

View Article and Find Full Text PDF